Brain Mann | NPR
Dec. 13, 2022
Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription.
The medication, an easy-to-use nasal spray version of the drug naloxone, has a strong track record reversing deadly opioid overdoses, which have soared in recent years largely because of the spread of fentanyl.
David Oliver | USA Today It’s festival season, meaning fabulous flower crowns, loud live music and Narcan. Yes, the overdose-reversing drug Narcan (naloxone) will be available at music festivals near you this year – and with good reason, experts say. Drugs and alcohol are staple at music festivals and many often overdo it. Combine that with the overwhelming presence of fentanyl in the drug…
By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….
Deepa Shivaram | NPR The White House is marshaling a new plan to try to beef up testing, tracking and treatment for street drugs laced with xylazine, a veterinary tranquilizer that has contributed to a surge of overdose deaths across the country. The administration listed xylazine combined with fentanyl as an emerging threat back in…
Marin parent Jessica Schiller, whose daughter Naomi died of an overdose, joined a panel discussion on fentanyl at the Marin County Office of Education (MCOE) which held a screening of the documentary, “Drugs in the Age of Fentanyl.” Marin County community-based prevention coalition, OD Free Marin collaborated on the event with Song for Charlie, a nonprofit…
By Sheraz Sadiq (OPB) In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were…
Nov 2 (Reuters) – CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line. CVS said on Wednesday it had agreed…